Lesopitron Dihydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLesopitron Dihydrochloride
Drug Alias Namelesopitronum来索吡琼盐酸盐盐酸来索吡琼E-4424
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEsteve Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEsteve Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank